Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Mol Cancer Res. 2017 May 23;15(8):1063–1072. doi: 10.1158/1541-7786.MCR-17-0062

Fig 5. Knock down of TPX2 attenuates 2-ME induced AR degradation.

Fig 5

(A) LNCaP and C4-2 cells were depleted of TPX2 and treated with or without 2-ME for 24 h. Cells were harvested and extracts were immunoblotted for indicated proteins. Tubulin serves as control. (B) Extracts from Fig 4 were immunoblotted for TPX2, tubulin serves as control.